Mild Cognitive Impairment
Conditions
Brief summary
Exercise interventions to prevent dementia and delay cognitive decline have gained considerable attention in recent years. Human and animal studies have demonstrated that regular physical activity targets brain function by increasing cognitive reserve. Although initial studies indicate enhanced cognitive performance in patients with mild cognitive impairment (MCI) following an exercise intervention, little is known about the effect of an extensive, controlled and regular exercise regimen on the neuropathology of patients with MCI. The aim of this study is to compare a 12- month aerobic exercise programme versus a stretching and toning (non-aerobic) programme versus a control group on the progression of cognitive decline in MCI. It is hypothesized that MCI-related decreases in cognitive and psychomotor functioning will show less progression or even be improved after a one-year aerobic exercise intervention compared to a group of patients undergoing stretching and toning exercise as well as to a control group provided with no intervention.
Detailed description
This randomised controlled clinical intervention study will take place across three European sites; the German Sport University Cologne, Germany, University of Nijmegen, The Netherlands and Trinity College Dublin, Ireland. Seventy-five previously sedentary patients with a clinical diagnosis of MCI will be recruited at each site. Participants will be randomised to one of three intervention arms. One group will receive a standardised one-year extensive aerobic exercise intervention (3 units of 45min / week). The second group will complete stretching and toning (non-aerobic) exercise (3 units of 45min / week) and the third group will receive usual care. Change in all outcomes will be measured at baseline (T0), after six months (T1) and after 12 months (T2).
Interventions
BEHAVIORALAerobic exercise
Patients with mild cognitive impairment will undergo a one-year aerobic exercise program of 3 units of 45 min / week
BEHAVIORALNon-aerobic exercise
Patients with mild cognitive impairment will undergo a one-year stretching and toning (non-aerobic) exercise program of 3 units of 45 min / week
Sponsors
German Sport University, Cologne
University of Dublin, Trinity College
University of Bonn
University Hospital, Bonn
Radboud University Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) according to the Albert et al (2011) criteria * Montreal Cognitive Assessment (MoCA) (Nasreddine et al. 2005) score 18-26 * Stable medical condition for more than 6 months * Stable medications for more than 3 months * Adequate visual and auditory acuity to complete neuropsychological testin * Electrocardiogram without significant abnormalities that might interfere with the study * Physical ability sufficient to allow performance of endurance exercise training * Capacity to provide written and dated informed consent form * Medical clearance to undergo a symptom-limited cardiopulmonary exercise test and extensive aerobic exercise training * Participants recruited from the community via newspaper articles and community advertisement will complete additional testing to determine MCI status. Participants must score ≤1.5 standard deviation (SD) of cut-off scores on episodic memory test
Exclusion criteria
* Diagnosis of AD or other type of dementia * History of familial early-onset dementia * Enrollment onto any investigational drug study * History in the past 2 years of epileptic seizures (Participants with epilepsy who have been stable off medication and seizure free for 2 years may be included) * Any major psychiatric disorder (a clinical diagnosis of major depressive disorder, bipolar or schizophrenia) * Past history or MRI evidence of brain damage, including significant trauma, stroke, hydrocephalus, mental retardation, or serious neurological disorder * Carotid stent or severe stenosis * History of myocardial infarction within previous year congestive heart failure (New York Heart Association Class II, III or IV) * Uncontrolled hypertension or hypotension (systolic blood pressure \>200 mm Hg and/or diastolic blood pressure \>110 mm Hg at rest) * Unstable cardiac, renal, lung, liver, or other severe chronic disease * Type 2 diabetes mellitus with hypoglycemia in the last 3 months * Significant history of alcoholism or drug abuse within last 10 years * Significant obesity limiting active participation in the exercise program * Engagement in moderate-intensity aerobic exercise training for more than 30 minutes, 3 times per week, during past 2 years * History of vitamin B12 deficiency or hypothyroidism (stable treatment for at least 3 months is allowed) * Serious or non-healing wound, ulcer, or bone fracture
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Cognitive performance | One year | Cognitive performance will be assessed by an extensive neuropsychological test battery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular fitness | One year | (sub)maximal ergometer exercise test |
| Physical activity | One year | Activity monitoring with accelerometers |
| Health related Quality of Life | One year | Health Related Quality of Life for People with Dementia (DemQOL) |
| Depressive symptoms | One year | Center for Epidemiologic Studies Depression (CES-D) |
| Neuroticism-Extraversion-Openness-Five Factor Inventory (NEO-FFI) | One year | Personality traits assessment |
| Global cognitive function | One year | MoCA (Montreal Cognitive Assessment) |
| Hand grip strength | One year | Frailty measurement |
| 30 second chair stand | One year | Frailty measurement |
| Epigenetics | One year | Genotyping of the Apolipoprotein E (APOE) 4 allele in venous blood. |
| Brain imaging | 6 months | Magnetic Resonance Imaging (MRI) scan: brain structure |
| Timed up and Go (TUG) | One year | Frailty measurement |
Countries
Germany, Ireland, Netherlands
Outcome results
None listed